ATLANTA--(BUSINESS WIRE)--Inhibitex, Inc. (NASDAQ: INHX), a biopharmaceutical company focused on developing products to treat and prevent serious infectious diseases, announced that Russell H. Plumb, President and Chief Executive Officer, is scheduled to present an overview of the company and its pipeline of differentiated antiviral compounds at the Deutsche Bank BioFEST Conference on Monday, December 5, 2011 at 2:15pm EST. The conference is being held at the Four Seasons Hotel in Boston, MA. The presentation will be simultaneously webcast and can be accessed by visiting the Investors section of the Inhibitex website at www.inhibitex.com. Shortly following the live webcast a replay will also be available on the Company website.
